Photo of Emmanuel Landau

Emmanuel Landau

  • PROFESSOR EMERITUS Psychiatry
  • PROFESSOR EMERITUS Pharmacology and Systems Therapeutics
Print ProfilePrint Profile

Education

  • Ph.D., Australian National University

  • Harvard University School of Medicine
    Neurobiology

  • Connecticut Valley Hospital
    Psychiatry

  • Yale University School of Medicine
    Psychiatry

Research

Study the role of the cyclic AMP (cAMP) signaling pathway in long-term potentiation (LTP).

One goal of the Landau and Blitzer Laboratory is to study the role of the cyclic AMP (cAMP) signaling pathway in long-term potentiation (LTP), and important example of neuronal plasticity and learning. Synaptic potentials are measured in slices of rat hippocampus, employing various types of electrophysiological recording (patch, intracellular, field). High frequency stimulation of the presynaptic fibers induces prolonged enhancement of synaptic transmission (LTP). The role of protein phosphatases in LTP, and their regulation by the cAMP pathway is studied by bath and intracellular application of enzyme inhibitors. Protein substrates of intracellular phosphatases and kinases are identified through labeling with specific antibodies. These studies are aimed at discovering the biochemical machinery of neuronal plasticity and finding pharmacological tools that influence learning and memory.

A second research area in the lab is to define a receptor for amyloid peptide (Ab). Ab is a major component of the plaques in Alzheimer's disease, and is implicated in the neurotoxicity of the illness. Using Xenopus oocytes injected with brain RNA, we have obtained evidence that Ab activates a receptor linked to phospholipase C (PLC). Since PLC activation has been shown to inhibit the formation of Ab such a receptor may play an important role in the pathogenesis and treatment of Alzheimer's disease. The aim of these studies is to characterize and clone the receptor for Ab.

Publications

Tsokas P, Ma T, Iyengar R, Landau EM, Blitzer RD. Mitogen-activated protein kinase upregulates the dendritic translation machinery in long-term potentiation by controlling the mammalian target of rapamycin pathway. J Neurosci 2007 May 30; 27(22): 5885-5894.

Garcia-Osta A, Tsokas P, Pollonini G, Landau EM, Blitzer R, Alberini CM. MuSK expressed in the brain mediates cholinergic responses, synaptic plasticity, and memory formation. J Neurosci 2006 July 26; 26(30): 7919-7932.

Landau EM. Teaching resources. Regulation of protein translation. Sci STKE 2006 Mar 7; 2006(325): tr3.

Tsokas P, Grace EA, Chan P, Ma T, Sealfon SC, Iyengar R, Landau EM, Blitzer RD. Local protein synthesis mediates a rapid increase in dendritic elongation factor 1A after induction of late long-term potentiation. J Neurosci 2005 Jun 15; 25(24): 5833-43.

Blitzer RD, Iyengar R, Landau EM. Postsynaptic signaling networks: cellular cogwheels underlying long-term plasticity. Biol Psychiatry 2005 Jan 15; 57(2): 113-19.

Giovannini MG, Blitzer RD, Wong T, Asoma K, Tsokas P, Morrison JH, Iyengar R, Landau EM. Mitogen-activated protein kinase regulates early phosphorylation and delayed expression of Ca2+/calmodulin-dependent protein kinase II in long-term potentiation. J Neurosci 2001 Sep 15; 21(18): 7053-7062.

Jordan JD, Landau EM, Iyengar R. Signaling networks: the origins of cellular multitasking. Cell 2000 Oct 13; 103(2): 193-200.

Brown GP, Blitzer RD, Connor JH, Wong T, Shenolikar S, Iyengar R, Landau EM. Long-term potentiation induced by theta frequency stimulation is regulated by a protein phosphatase-1-operated gate. J Neurosci 2000 Nov 1; 20(21): 7880-7887.

Blitzer RD, Wong T, Giovannini MG, Pangalos MN, Robakis NK, Landau EM. Amyloid beta peptides activate the phosphoinositide signaling pathway in oocytes expressing rat brain RNA. Brain Res Mol Brain Res 2000 Mar 10; 76(1): 115-20.

Blitzer RD, Connor JH, Brown GP, Wong T, Shernolikar S, Iyengar R, Landau EM. Gating of CaMKII by cAMP-regulated phosphatses activity during LTP. Science 1998; 280: 1940-1943.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr.Landau is not currently required to report Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

James J Peters Veteran Adminis
130 West Kingsbridge Road
Bronx, NY 10468

Tel: 718-584-9000